Menu
Search
Home > Courses > Hypogonadism in Older HIV-Infected Men: Current Concepts and Controversies

Hypogonadism in Older HIV-Infected Men: Current Concepts and Controversies

Hypogonadism in Older HIV-Infected Men: Current Concepts and Controversies
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Original Release Date: 12/13/2011
Review Date: 7/20/2012
Presenter
  • Todd T. Brown, MD, PhD
    Associate Professor of Medicine
    Johns Hopkins University
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Discuss the optimal screening recommendations regarding hypogonadism and the current controversies.
  2. Discuss the potential risks and benefits of testosterone therapy, particularly with respect to the older male.
Presenter Bio
Todd Brown, MD, PhD
Dr. Brown is a Professor of Medicine and Epidemiology in the Division of Endocrinology, Diabetes, and Metabolism at Johns Hopkins University where he is also the primary endocrine consultant to the Johns Hopkins HIV Clinic. He is a graduate of Columbia University College of Physicians and Surgeons and the Johns Hopkins Bloomberg School of Public Health. He completed his clinical training at Georgetown University and Johns Hopkins. His research focuses on metabolic, endocrine, and skeletal abnormalities observed in HIV-infected patients, as related to aging. Dr. Brown is particularly interested in the aging-related outcomes of cardiovascular disease, fractures, and frailty in persons living with HIV. He is a co-investigator in the Multicenter AIDS Cohort Study and the AIDS Clinical Trial Group. In the MACS, he is the co-Principal Investigator of the Baltimore/Washington DC site and is the former chair of the Metabolic Working Group. In the ACTG, he has served in leadership positions on multiple observational and interventional studies, including a substudy of REPRIEVE, the large statin trial in low CVD risk, persons living with HIV. He is a member of the Organizing Committee of the International Workshop on Comorbidities and Adverse Drug Reactions in HIV, now in its 20th year. He has published over 170 articles and book chapters on endocrine and metabolic problems and their consequences in HIV-infected persons and has lectured internationally on these topics.
PRN Learning Modules